Community Health Network Community Fairbanks Behavioral Health

Open Now
0.000
Contact Information
2040 North Shadeland Avenue Suites 200 and 250, Indianapolis, Indiana 46219, United States
Detailed Information

Community Health Network Community Fairbanks Behavioral Health

    Services:
    Gender Accepted

    • Female
    • Male

    Testing

    • Drug or alcohol urine screening
    • Drug and alcohol oral fluid testing
    • HIV testing

    Facility Vaping Policy

    • Vaping not permitted

    External Source of Medications Used for Alcohol Use Disorder Treatment

    • Other contracted prescribing entity
    • No formal relationship with prescribing entity
    • In-network prescribing entity

    Pharmacotherapies

    • Naltrexone (oral)
    • Buprenorphine (extended-release, injectable)
    • Buprenorphine with naloxone
    • Acamprosate (Campral®)
    • Naltrexone (extended-release, injectable)
    • Medication for mental disorders
    • Disulfiram
    • Buprenorphine without naloxone
    • Non-nicotine smoking/tobacco cessation
    • Nicotine replacement

    Age Groups Accepted

    • Children/Adolescents

    Payment/Insurance/Funding Accepted

    • Medicaid
    • Federal, or any government funding for substance use treatment programs
    • Private health insurance
    • State-financed health insurance plan other than Medicaid
    • Federal military insurance (e.g., TRICARE)
    • Cash or self-payment
    • Medicare

    Facility Operation (e.g., Private, Public)

    • Private non-profit organization

    Assessment/Pre-treatment

    • Comprehensive substance use assessment
    • Screening for tobacco use
    • Outreach to persons in the community
    • Screening for mental disorders
    • Comprehensive mental health assessment
    • Screening for substance use

    Type of Alcohol Use Disorder Treatment

    • This facility administers/prescribes medication for alcohol use disorder

    Hospitals

    • General Hospital (including VA hospital)

    License/Certification/Accreditation

    • State mental health department
    • State Substance use treatment agency
    • The Joint Commission
    • State department of health
    • Hospital licensing authority

    Treatment Approaches

    • Cognitive behavioral therapy
    • Telemedicine/telehealth therapy
    • 12-step facilitation
    • Substance use disorder counseling
    • Matrix Model
    • Brief intervention
    • Motivational interviewing
    • Anger management
    • Relapse prevention
    • Trauma-related counseling

    Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

    • Outpatient
    • Regular outpatient treatment
    • Outpatient methadone/buprenorphine or naltrexone treatment

    Special Programs/Groups Offered

    • Pregnant/postpartum women
    • Adult men
    • Adolescents
    • Clients who have experienced sexual abuse
    • Clients who have experienced trauma
    • Young adults
    • Adult women
    • Clients with co-occurring pain and substance use disorders
    • Clients with co-occurring mental and substance use disorders
    • Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)

    Type of Opioid Treatment

    • Prescribes naltrexone
    • Relapse prevention with naltrexone
    • Prescribes buprenorphine

    Ancillary Services

    • Social skills development
    • Suicide prevention services
    • Mental health services
    • Case management service

    Recovery Support Services

    • Assistance with obtaining social services
    • Housing services
    • Mentoring/peer support
    • Employment counseling or training

    Facility Smoking Policy

    • Smoking not permitted

    Other Services

    • Treatment for other addiction disorder

    Opioid Medications used in Treatment

    • Naltrexone used in Treatment
    • Buprenorphine used in Treatment

    Education and Counseling Services

    • Smoking/vaping/tobacco cessation counseling
    • Group counseling
    • Family counseling
    • Substance use disorder education
    • Individual counseling

    Transitional Services

    • Naloxone and overdose education
    • Discharge Planning
    • Aftercare/continuing care
    • Outcome follow-up after discharge

    Type of Care

    • Substance use treatment
    • Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm